Microarray gene expression profiling and analysis in renal cell carcinoma
- Louis S Liou†1, 2, 6,
- Ting Shi†1,
- Zhong-Hui Duan4,
- Provash Sadhukhan1, 2,
- Sandy D Der5,
- Andrew A Novick2,
- John Hissong1,
- Marek Skacel3,
- Alexandru Almasan1 and
- Joseph A DiDonato1Email author
© Liou et al; licensee BioMed Central Ltd. 2004
Received: 28 January 2004
Accepted: 22 June 2004
Published: 22 June 2004
Renal cell carcinoma (RCC) is the most common cancer in adult kidney. The accuracy of current diagnosis and prognosis of the disease and the effectiveness of the treatment for the disease are limited by the poor understanding of the disease at the molecular level. To better understand the genetics and biology of RCC, we profiled the expression of 7,129 genes in both clear cell RCC tissue and cell lines using oligonucleotide arrays.
Total RNAs isolated from renal cell tumors, adjacent normal tissue and metastatic RCC cell lines were hybridized to affymatrix HuFL oligonucleotide arrays. Genes were categorized into different functional groups based on the description of the Gene Ontology Consortium and analyzed based on the gene expression levels. Gene expression profiles of the tissue and cell line samples were visualized and classified by singular value decomposition. Reverse transcription polymerase chain reaction was performed to confirm the expression alterations of selected genes in RCC.
Selected genes were annotated based on biological processes and clustered into functional groups. The expression levels of genes in each group were also analyzed. Seventy-four commonly differentially expressed genes with more than five-fold changes in RCC tissues were identified. The expression alterations of selected genes from these seventy-four genes were further verified using reverse transcription polymerase chain reaction (RT-PCR). Detailed comparison of gene expression patterns in RCC tissue and RCC cell lines shows significant differences between the two types of samples, but many important expression patterns were preserved.
This is one of the initial studies that examine the functional ontology of a large number of genes in RCC. Extensive annotation, clustering and analysis of a large number of genes based on the gene functional ontology revealed many interesting gene expression patterns in RCC. Most notably, genes involved in cell adhesion were dominantly up-regulated whereas genes involved in transport were dominantly down-regulated. This study reveals significant gene expression alterations in key biological pathways and provides potential insights into understanding the molecular mechanism of renal cell carcinogenesis.
Renal cell carcinoma (RCC) accounts for 3% of all malignancies with about 30,000 new cases and 12,000 deaths each year in the United States. RCC is the most common cancer in adult kidney and the most lethal cancer of the urinary system. The incidence of RCC has been increasing at a rate of 3% per year in the United States and Europe. Histopathologically, RCC is a heterogeneous disease. The five distinct types of RCC include clear cell (70–80%), papillary (15–20%), chromophobe (4–5%), collecting duct (<1%) and medullary cell (<1%) . The most common RCC, clear cell RCC, is believed to originate from the proximal tubule epithelium. It is mostly sporadic, unilateral, and unifocal . The main genetic alterations of clear cell RCC have been identified to be chromosome 3 alterations and Von Hippel-Landau gene mutations .
The diagnosis of RCC is often confirmed by imaging studies such as computed tomography and X-ray, but the possible existence of benign renal tumors can be a serious challenge to the diagnosis. Previous studies have shown that RCC is one of the most therapy-resistant cancers. It responds very poorly or not at all to chemotherapy, hormonal therapy and radiation therapy [2, 3]. Even for the immunotherapy, the response rate is only 10–15% and mostly the response is partial . Surgery thus remains to be the main method of treatment for RCC although it is effective only in about 70% of early-stage and localized RCC [2, 4]. The prognosis of RCC is mainly based on the clinical stage and pathological grade of the disease. A review of the Cleveland Clinic Foundation's nephrectomy database with a 10-year follow-up revealed that the size and stage of tumor had the best prognostic value whereas the surgical margin width was not significant [5, 6]. This suggests that patients' outcomes with surgery are primarily dependent on tumor biology. Therefore, the advances in our understanding of the genetics and biology of RCC are essential to improve the current diagnosis, treatment and prognosis of RCC.
The emergence of DNA microarray technology made it possible to investigate the expression of thousands of genes simultaneously [7–13]. The large-scale analysis of the gene expression levels can provide insights into the underlying molecular mechanism of RCC and possibly lead to the finding of molecular tumor markers that can potentially be used for more accurate diagnosis, prognosis and possibly can serve as drug targets for effective therapies. Recently, microarray gene expression profiling has been performed to identify gene expression patterns for many solid and hematological malignancies such as colon cancer, breast cancer, prostate cancer, leukemia, and lymphoma [14–20]. Molecular profiling of RCC using cDNA microarrays has also been reported [21–26]. Using a 31,500-element cDNA array, Boer et al. identified 1,738 differentially expressed genes in clear cell RCC. Three hundred and twenty-one of them were annotated for biological processes . Takahashi et al. identified 109 differentially expressed genes in 29 clear cell RCC samples. Approximately 40 genes were then used in a simulation to verify the clinical outcomes of 29 patients. The accuracy of the prediction was reported to exceed that of prediction based on staging . Young et al. analyzed the gene expression patterns of 7075 genes for four types of RCC including clear cell RCC and identified 189 differentially expressed genes among the four different types . More recently, Higgins et al. compared the gene expression profiles of diverse histological types including clear cell, papillary and chromophobe RCC. One thousand five hundred and fifty differentially expressed genes were identified .
To better understand the genetics and biology of clear cell RCC, we profiled the expression of 7129 genes in two pooled RCC tissue samples, two patient-matched normal tissues and two pooled RCC cell lines using oligonucleotide arrays. The gene expression profiles were analyzed and visualized using singular value decomposition analysis. A subset of differentially expressed genes identified in this study is common to those discovered previously. Based on biological process ontology, selected genes were annotated and clustered extensively. The analysis of the expression profiles of genes in the annotated functional groups provides insights into biological pathways of RCC. Moreover, comparison of expression patterns in RCC tissue samples and RCC cell lines reveals significant differences between the two types of samples.
Tissue samples and RCC cell lines
Six clear cell RCC tissue samples (four of them were Fuhrman grade 3, one Fuhrman grade 2, one Fuhrman grade 1) along with six corresponding patient-matched normal kidney tissue samples were obtained from patients undergoing partial or radical nephrectomy at the Cleveland Clinic Foundation. Institutional review board approval and informed consent from patients were obtained and tissue samples were frozen and stored at -80°C immediately after surgery. All the RCC tumors were at the early stages of development (five at stage 1 and one at stage 2). The ages of patients were around sixty years old. Five patients were white male and one was white female. Metastatic RCC cell lines, RCC13 and RCC54  were obtained from Memorial Sloan-Kettering Cancer Center.
RNA extraction and microarray experiments
For microarray experiments, six pairs of RCC tissues and patient-matched normal kidney tissues (total of twelve frozen tissue samples) were mechanically disrupted in TriZol reagent (Life Technologies, Inc.) using a PowerGen 35 tissue homogenizer (Fisher Scientific) and total RNA was immediately isolated from each tissue sample following the manufacturer's procedures (Invitrogen, Carlsbad, CA). Six RCC tissue samples were divided into two groups with three RCC tissue samples in each group. One group includes two Fuhrman grade 3 RCC tissue samples and one Fuhrman grade 1 RCC tissue sample. The other group includes two Fuhrman grade 3 RCC tissue samples and one Fuhrman grade 1 RCC tissue sample. Six corresponding patient-matched normal samples were divided into two groups accordingly. A total of four groups of tissue samples were thus generated, two RCC tissue groups and two normal kidney tissue groups. For each group, 10 μg of total RNA from each tissue sample were pooled. Four pooled total RNA samples from tissues were thus generated. Also, one pooled total RNA sample was generated by pooling 10 μg of total RNA isolated from each of the two RCC cell lines. Double-stranded cDNAs were synthesized from 10 μg of each total RNA sample using SuperScript Choice double-stranded cDNA synthesis kit from Invitrogen following the manufacturer's protocol. cDNAs were purified by phenol/chloroform extraction and ethanol precipitation. Biotin-labeled cRNAs were synthesized by an in vitro transcription reaction using the BioArray HighYield RNA Transcript Labeling Kit (Enzo Diagnostics, Farmingdale, NY). cRNAs were purified from the in vitro transcription reaction using RNeasy Mini kit (Qiagen, Valencia, CA). The fragmentation of biotin-labeled cRNAs and hybridization of the fragments to HuFL Oligonucleotide Arrays (Affymetrix, Santa Clara, CA) were performed following the manufacturer's protocol. The Oligonucleotide Arrays were washed and stained according to the Affymetrix protocol Midi-3 Euk2v3, and scanned using a Hewlett-Parkard GeneArray scanner (Hewlett-Parkard, Palo Alto, CA) with a 570 nM filter and a pixel size of 3 μM. For RT-PCR experiments, total RNAs were isolated from eight additional pairs of RCC tissues and patient-matched normal kidney tissues using the same methods described above.
Raw data were acquired using Microsuite 5.1 software of Affymetrix and normalized following a standard practice of scaling the average of all gene signal intensities to a common arbitrary value. The 7,129 genes were preprocessed to eliminate the genes whose signal intensities were not significantly different from their background levels and thus labeled as "Absent" by MicroSuite 5.1. After elimination, 3,145 genes remained for further analysis.
Functional clustering analysis
To analyze the expression profiles of genes in different biological functional groups, 1340 of the 3145 selected genes were annotated for biological process using the software GeneSpring from Silicon Genetics. The ontology is based on the description of the Gene Ontology Consortium . The annotated genes were then categorized into functional groups and analyzed based on the gene expression levels.
cDNA was synthesized by reverse transcription of 2.5 μg total RNA using oligo(dT)12–18 and SuperScript II RNA H-reverse transcriptase (Invitrogen). Using the same cDNA preparation as template, DNA fragments of SLC6A3, BIGH3 and vWF were amplified by 35 PCR cycles using Taq polymerase (Invitrogen). Normalization was made using α-tubulin. Primers used for the PCR amplifications are as follows:
SLC6A3, sense: 5'-CACCGTGCGTGCCACATCAATAAC-3',
BIGH3, sense: 5'-CACCCCGCACCATAATGAGATGTG-3',
vWF, sense: 5'-GTGACGGTGAATGGGAGACTGG-3',
α-tubulin, sense: 5'-CTGCCATTGCCACCATCAAAACCAA-3',
The PCR products were separated on 2% agrose gels, stained with ethidium bromide and visualized using the Flouro-Chem imaging system (Alpha InnoTech Cooperation).
Singular value decomposition
Singular value decomposition is a very powerful method to analyze and compare the subspaces associated with a matrix. It has been widely used in data compression and visualization . Recently there have been many applications of SVD to analyze microarray gene expression data [30–34]. Following the notation of van Loan , the SVD of a real m-by-n (m≥n) matrix A can be written as:
A = UΣVT,
where U = [u1,u2,...,un]∈ Rmxn and V = [v1,v2,...,vn]∈ Rnxn are orthogonal matrices and Σ = diag(σ1, ... ,σn)∈ Rnxn is a diagonal matrix and σ1≥ ... ≥σr≥σr+1 = ... = σn = 0. The vectors ui and vi are the ith left and right singular vectors respectively, σi are the singular values of A, and r is called the rank of A. Based on the structure of the decomposition, the SVD expansion can be readily obtained
The magnitudes of singular values indicate how close a given matrix A is to a matrix of lower rank. In gene expression data analysis, each column of A represents the expression profile of a corresponding sample and each row represents the transcriptional response of a specific gene. The singular values indicate how well a lower dimensional linear projection of the expression data can represent the original data. The projection onto a subspace spanned by the first p left/right singular vectors can be described by
Analyzing and visualizing a resulting lower dimensional projection can provide a great insight into understanding the inherent structure of the original data. In this study, the gene expression data was projected onto a 2-D subspace spanned by the first two left singular vectors.
Patterns of gene expression alterations in RCC tissue samples
Commonly up-regulated genes in both RCC tissue samples
Dopamine transporter (SLC6A3)
Fibronectin 1 1,2,4
Neuronal pentraxin II (NPTX2)
Serum amyloid A (SAA) (_s_at)1
Serum amyloid A (SAA)1
Serum amyloid A (SAA) (_at)1
Transforming growth factor-beta induced gene product (BIGH3)1,3,4
Lymphoid-restricted membrane protein (Jaw1)
von Willebrand factor (vWF)1,2,3
Inhibitor of apoptosis protein 1
Fibronectin receptor alpha subunit1
Tissue factor pathway inhibitor-2
Apolipoprotein C-I (VLDL)1,2,4
Alpha-2 collagen type IV (COL4A2)1,4
MaTu MN for p54/58N
Insulin-like growth factor-binding protein-31,2,4
Laminin-related protein (LamA3)
Hemopoietic cell protein-tyrosine kinase (HCK)4
Retinoic acid inducible factor (MK)
Carboxypeptidase E (EC 184.108.40.206)
Commonly down-regulated genes in both RCC tissue samples
Avg. fold change
Liver fatty acid binding protein (FABP1)2
Kininogen (KNG) (cds2)1,2,3
Na/Cl electroneutral thiazide-sensitive cotransporter
Cytochrome P450 4F2 (CYP4F2)3
Sodium/glucose cotransporter protein1
Microsomal dipeptidase (MDP)1
Cytochrome P450-IIB (hIIB1)
Kininogen (KNG) (cds1) 1,2,3
Parathyroid hormone-related peptide receptor1
4-hydroxyphenylpyruvic acid dioxygenase (HPD)1,3
Antithrombin III (ATIII) Utah gene4
Vitamin D receptor
Phosphoenolpyruvate carboxykinase (PCK1)1,2,4
Phosphoenolpyruvate carboxykinase (PCK1)1,2,4
Chromosome 19 cosmid F19541
Phenylalanine hydroxylase (PAH) 2,3
4-aminobutyrate aminotransferase (GABAT)
Aromatic amino acid decarboxylase
Aldolase B (ALDOB)1,2
S100A2, exon 1, 2 and 31
Alpha (1,3) fucosyltransferase (FUT6)
Prostatic acid phosphatase
Crystallin, Alpha A1
FGF, exon 3
Phosphoenolpyruvate carboxykinase (PCK1)1,2,4
Alpha (1,3/1,4) fucosyltransferase (FUT3)
Similar to L-glycerol-3-phosphate:NAD oxidoreductase and albumin1
Patterns of gene expression alterations in RCC cell line
Numbers of differentially expressed genes in RCC tissues and RCC cell lines
RCC cell line
Singular value decomposition analysis
We analyzed the gene expression profiles of both clear cell RCC tissues and a RCC cell lines using functional clustering analysis and singular value decomposition. The expression levels of the genes in certain functional groups, such as cell adhesion and transport, were either mainly up-regulated or down-regulated, while the expression levels of many other groups such as metabolism, do not show clear patterns. Interestingly, all of the five at least 5-fold differentially expressed genes in the cell adhesion group are up-regulated in RCC (Table 1). The five genes are laminin A3, fibronectin 1, fibronectin receptor alpha subunit, vWF, and BIGH3. This greatly altered cell adhesion expression is very likely associated with carcinogenesis, tumor invasion and metastasis. Laminin A3 is the alpha 3 chain of laminin 5, which is an adhesive glycoprotein in the extracellular matrix. The laminins mediate the attachment, migration and organization of cells into tissues by interacting with other extracellular matrix components . The association of laminin A3 with carcinogenesis has been reported for other types of cancers such as lung cancer . Interestingly, the expression of laminin A3 was suppressed in lung cancer in contrast with its over-expression in RCC found in this study. Fibronectin 1 is another adhesive protein that binds to the external face of the plasma membrane and enables cells to interact with the extracellular matrix . The cell-binding region of fibronectin 1 binds and releases integrin, a complex of proteins that span the plasma membrane. vWF is a plasma protein. It mediates platelet adhesion to the injured vessel wall and carries and protects coagulation factor VIII. At the site of vascular damage, vWF binds immediately to exposed collagens, thereby facilitating the adhesion of platelets . BIGH3 encodes a secreted adhesion molecule, which is believed to be involved in tumor progression by regulating integrin receptors . The over-expression of fibronectin 1, fibronectin receptor alpha subunit, vWF, and BIGH3 have all been reported previously in RCC and/or other types of cancers [22–24, 26, 41, 42]. Like many other genes, the five genes are playing many different roles in biological processes. Laminin A3, fibronectin receptor alpha subunit, and BIGH3 are also associated with integrin receptor signaling. BIGH3 is also involved in cell growth and proliferation, while fibronectin 1 is also involved in cell motility and transduction in developmental processes. vWF plays roles in blood coagulation. The 27 remaining over-expressed genes are mainly associated with cell growth, metabolism, proliferation, and transduction in developmental processes.
Table 2 shows the genes that are at least 5-fold down-regulated in RCC tissue. These include five of the six at least 5-fold differentially expressed genes involved in transport are found in the table. They include the renal Na/Pi cotransporter, Na/Cl electro-neutral thiazide-sensitive cotransporter, sodium/glucose cotransporter, liver fatty acid binding protein (FABP1), and lactoferrin (LTF). Notably, the cotransporters are all remarkably down-regulated. The renal Na/Pi-cotransporter is localized at the apical membrane of the proximal tubular cells . It is believed to play an important role in the maintenance of phosphate homeostasis in the kidney. Reabsorption of phosphate in the kidney occurs predominately in the proximal tubule. This process is mediated mainly by Na+ dependent Na/Pi cotransporter in the brush border membrane and is regulated by a variety of hormones, including insulin-like growth factor. Na/Cl electro-neutral thiazide-sensitive cotransporter is highly and specifically expressed in epithelial cells of distal convoluted tubule of the kidney . It drives the movement of chloride across the membrane of epithelial cells and thus maintains to the chloride homeostasis. The sodium/glucose cotransporter is located in the early proximal convoluted tubule. It is involved in the reabsorption of D-glucose in the kidney . The remarkable under-expression of the cotransporters clearly indicates that the disruption of electrolyte homeostasis maintained by ion transport systems is associated with RCC carcinogenesis. FABP1 is in a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. LTF is an important member of the transferrin family that plays an essential role in the transport of iron to all tissue cells. Since LTF is carried in the bloodstream, its level can be easily monitored, with the gene expression alteration of LTF having a greater potential to be used for early diagnosis of RCC.
The comparison of gene expression profiles in RCC tissues and the cell lines shows significant differences between the expression patterns of the two different types of samples. Three factors that might contribute to these differences include (1) the RCC cell lines were derived from metastatic RCC. Therefore, possibly more gene mutations were accumulated and thus more genes were differentially expressed; (2) the RCC cell lines are a pure population of cancer cells in contrast to the RCC tissue samples that contain many other different types of cells besides cancer cells. Thus the expression intensity of differentially expressed genes was magnified in the RCC cell lines; (3) the in vitro culture of the RCC cell lines may have introduced changes in the gene expression profile as compared with in vivo cancer cells in the RCC tissue samples. On the other hand, many important genes were consistently expressed in both types of samples, suggesting that some of the gene expression patterns in RCC tissues can be recognized through the study of the gene expression in RCC cell lines. In this study, all the genes associated with cell adhesion that were discussed above, laminin A3, fibronectin 1, fibronectin receptor alpha subunit, and BIGH3 except vWF were consistently up-regulated in the RCC cell lines. The expression intensity of vWF in the RCC cell lines was not significantly different from the background, thus vWF was not selected for the analysis of the cell line profile. We note that the up-regulation of vWF in RCC tissue samples has been reported [22–24]. The five genes involved in transport, renal Na/Pi cotransporter, Na/Cl electro-neutral thiazide-sensitive cotransporter, sodium/glucose cotransporter, FABP1 and LTF are all remarkably down-regulated in the RCC cell lines, which is consistent with the results from the RCC tissue samples.
This study has identified 74 gene expression alterations in clear cell RCC. The majority (~64%) of these alterations has been reported in RCC previously. Extensive annotation, clustering and analysis of a large number of genes based on the gene functional ontology revealed many interesting gene expression patterns in RCC. Most notably, genes involved in cell adhesion were up-regulated whereas genes involved in transport were down-regulated. The identified alterations of gene expression will likely give insight into RCC carcinogenesis and tumor progression. Our initial, detailed comparison of gene expression profiles in RCC tissue and cell lines revealed significant differences of gene expression patterns between the two types of samples.
cell renal cell carcinoma
reverse transcription polymerase chain reaction
singular value decomposition
transforming growth factor-beta induced gene product
von Willebrand factor
liver fatty acid binding protein
The work was partly supported by grants to J. A. DiDonato from the National Institute of Health, Department of Defense, and the Wilson Foundation and a start-up grant to Z-H. Duan from The University of Akron and an National Institute of Health grant (CA 82858) to A. Almasan.
- Reuter VE, Presti JC: Contemporary approach to the classification of renal epithelial tumors. Semin Oncol. 2000, 27: 124-37.PubMedGoogle Scholar
- Walsh PC, Retik AB, Vaughan ED, Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA: Campbell's Urology. 2003, Philadelphia, London, New York, St. Louis, Sydney, Toronto: Saunders, 8Google Scholar
- Amato RJ: Chemotherapy for renal cell carcinoma. Semin Oncol. 2000, 27: 177-86.PubMedGoogle Scholar
- Russo P: Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol. 2000, 27: 160-176.PubMedGoogle Scholar
- Fergany AF, Hafez KS, Novick AC: Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000, 163: 442-445.View ArticlePubMedGoogle Scholar
- Castilla EA, Liou LS, Abrahams NA, Fergany A, Rybicki LA, Myles J, Novick AC: Prognostic importance of the width of the resection margin after nephron-sparing surgery for renal cell carcinoma. Urology. 2002, 60: 993-997. 10.1016/S0090-4295(02)01983-0.View ArticlePubMedGoogle Scholar
- DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet. 1996, 14: 457-60.View ArticlePubMedGoogle Scholar
- Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996, 14: 1675-80.View ArticlePubMedGoogle Scholar
- Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW: Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci. 1996, 93: 10614-9. 10.1073/pnas.93.20.10614.View ArticlePubMedPubMed CentralGoogle Scholar
- Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci. 1997, 94: 2150-2155. 10.1073/pnas.94.6.2150.View ArticlePubMedPubMed CentralGoogle Scholar
- Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999, 286: 531-537. 10.1126/science.286.5439.531.View ArticlePubMedGoogle Scholar
- Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000, 24: 227-235. 10.1038/73432.View ArticlePubMedGoogle Scholar
- King HC, Sinha AA: Gene expression profile analysis by DNA microarrays: promise and pitfalls. JAMA. 2001, 286: 2280-2288. 10.1001/jama.286.18.2280.View ArticlePubMedGoogle Scholar
- Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, Vedvick TS, Leslie KB, Badaro R, Reed SG: Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000, 60: 1677-1682.PubMedGoogle Scholar
- Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI: Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res. 2001, 61: 4483-4489.PubMedGoogle Scholar
- Brenton JD, Aparicio SA, Caldas C: Molecular profiling of breast cancer: portraits but not physiognomy. Breast Cancer Res. 2001, 3: 77-80. 10.1186/bcr274.View ArticlePubMedGoogle Scholar
- Li S, Ross DT, Kadin ME, Brown PO, Wasik MA: Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray. Am J Pathol. 2001, 158: 1231-1237.View ArticlePubMedPubMed CentralGoogle Scholar
- Takemasa I, Higuchi H, Yamamoto H, Sekimoto M, Tomita N, Nakamori S, Matoba R, Monden M, Matsubara K: Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer. Biochem Biophys Res Commun. 2001, 285: 1244-1249. 10.1006/bbrc.2001.5277.View ArticlePubMedGoogle Scholar
- Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet. 2002, 31: 141-149. 10.1038/ng892.View ArticlePubMedGoogle Scholar
- Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003, 33: 49-54. 10.1038/ng1060.View ArticlePubMedGoogle Scholar
- Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser TH, Mihatsch MJ, Kallioniemi OP, Sauter G: Identification of Potential Prognostic Parameters for Renal Cell Carcinoma by Tissue Microarray Analysis and cDNA Microarrays Screening. Verh Dtsch Ges Path. 1999, 83: 225-232.Google Scholar
- Boer JM, Huber WK, Sültmann H, Wilmer F, von Heydebreck A, Haas S, Korn B, Gunawan B, Vente A, Füzesi L, Vingron M, Poustka A: Identification and Classification of Differentially Expressed Genes in Renal Cell Carcinoma by Expression Profiling on a Global Human 31,500-Element cDNA Array. Genome Research. 2001, 11: 1861-1870.PubMedPubMed CentralGoogle Scholar
- Takahashi M, Rhodes DR, Furge KA, Kanayama HO, Kagawa S, Haab BB: Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification. Proc Natl Acad Sci. 2001, 98: 9754-9759. 10.1073/pnas.171209998.View ArticlePubMedPubMed CentralGoogle Scholar
- Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS: Expression Profiling of Renal Epithelial Neoplasms: A Method for Tumor Classification and Discovery of Diagnostic Molecular Markers. American Journal of Pathology. 2001, 158: 1639-1651.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhou M, Rubin MA: Molecular Markers for renal cell carcinoma: Impact on diagnosis and treatment. Seminars in Urologic Oncology. 2001, 19: 80-87.PubMedGoogle Scholar
- Higgins JPT, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, Van de Rijn M, Brooks JD: Gene Expression Patterns in Renal Cell Carcinoma Assessed by Complementary DNA Microarray. Am J Pathol. 2003, 162: 925-932.View ArticlePubMedPubMed CentralGoogle Scholar
- Ebert T, Bander NH, Finstad CL, Ramsawak RD, Old LJ: Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res. 1990, 50: 5531-5536.PubMedGoogle Scholar
- Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al: Gene Ontology: tool for the unification of biology. Nat Genet. 2000, 25: 25-29. 10.1038/75556.View ArticlePubMedPubMed CentralGoogle Scholar
- Gulob GH, van Loan CF: Matrix computations. 1996, Baltimore and London: The Johns Hopkins University Press, 3Google Scholar
- Alter O, Brown PO, Botstein D: Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci. 2000, 97: 10101-10106. 10.1073/pnas.97.18.10101.View ArticlePubMedPubMed CentralGoogle Scholar
- Holter NS, Mitra M, Maritan A, Cieplak M, Banavar JR, Fedoroff NV: Fundamental patterns underlying gene expression profiles: Simplicity from complexity. Proc Natl Acad Sci. 2000, 97: 8409-8414. 10.1073/pnas.150242097.View ArticlePubMedPubMed CentralGoogle Scholar
- Holter NS, Maritan A, Cieplak M, Fedoroff NV, Banavar JR: Dynamic modeling of gene expression data. Proc Natl Acad Sci. 2001, 98: 1693-1698. 10.1073/pnas.98.4.1693.View ArticlePubMedPubMed CentralGoogle Scholar
- Yeung MKS, Tegner J, Collins JJ: Reverse engineering gene networks using singular value decomposition and robust regression. Proc Natl Acad Sci. 2002, 99: 6163-6168. 10.1073/pnas.092576199.View ArticlePubMedPubMed CentralGoogle Scholar
- Wall ME, Rechtsteiner A, Rocha LM: Singular Value Decomposition and Principal Component Analysis. In A Practical Approach to Microarray Data Analysis. Edited by: Berrar DP, Dubitzky W, Granzow M. 2003, Boston: Kluwer Academic Publishers, 91-109.View ArticleGoogle Scholar
- Shi T, Dong F, Liou LS, Duan ZH, Novick AC, DiDonato JA: Differential protein Profiling in renal-cell carcinoma. Mol Carcinog. 2004, 40: 47-61. 10.1002/mc.20015.View ArticlePubMedGoogle Scholar
- Kariya Y, Tsubota Y, Hirosaki T, Mizushima H, Puzon-McLaughlin W, Takada Y, Miyazaki K: Differential regulation of cellular adhesion and migration by recombinant laminin-5 forms with partial deletion or mutation within the G3 domain of alpha3 chain. J Cell Biochem. 2003, 88: 506-20. 10.1002/jcb.10350.View ArticlePubMedGoogle Scholar
- Akashi T, Ito E, Eishi Y, Koike M, Nakamura K, Burgeson RE: Reduced expression of laminin alpha 3 and alpha 5 chains in non-small cell lung cancers. Jpn J Cancer Res. 2001, 92: 293-301.View ArticlePubMedGoogle Scholar
- Yamada KM, Olden K: Fibronectins: adhesive glycoproteins of cell surface and blood. Nature. 1978, 275: 179-84.View ArticlePubMedGoogle Scholar
- Denis CV: Molecular and cellular biology of von Willebrand factor. Int J Hematol. 2002, 75: 3-8.View ArticlePubMedGoogle Scholar
- Zhao YL, Piao CQ, Hei TK: Overexpression of Betaig-h3 gene downregulates integrin alpha5beta1 and suppresses tumorigenicity in radiation-induced tumorigenic human bronchial epithelial cells. Br J Cancer. 2002, 86: 1923-1928. 10.1038/sj.bjc.6600304.View ArticlePubMedPubMed CentralGoogle Scholar
- Sonmez HS, Karaarslan I, Baloglu H, Kokoglu E: Tissue fibronectin levels of human prostatic cancer, as a tumor marker. Cancer Biochem Biophys. 1995, 15: 107-110.PubMedGoogle Scholar
- Suer S, Sonmez H, Karaaslan I, Baloglu H, Kokoglu E: Tissue sialic acid and fibronectin levels in human prostatic cancer. Cancer Lett. 1996, 99: 135-7. 10.1016/0304-3835(95)04084-6.View ArticlePubMedGoogle Scholar
- Murer H, Hernando N, Forster I, Biber J: Regulation of Na/Pi transporter in the proximal tubule. Annu Rev Physiol. 2003, 65: 531-42. 10.1146/annurev.physiol.65.042902.092424.View ArticlePubMedGoogle Scholar
- Obermuller N, Bernstein P, Velazquez H, Reilly R, Moser D, Ellison DH, Bachmann S: Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney. Am J Physiol. 1995, 269: 900-10.Google Scholar
- Santer R, Kinner M, Lassen CL, Schneppenheim R, Eggert P, Bald M, Brodehl J, Daschner M, Ehrich JH, Kemper M, Li Volti S, Neuhaus T, Skovby F, Swift PG, Schaub J, Klaerke D: Molecular analysis of the SGLT2 gene in patients with renal glucosuria. J Am Soc Nephrol. 2003, 14: 2873-82.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2490/4/9/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.